ES2031477T3 - Procedimiento para producir esteres de acido 1-hidroxi-5-oxo-5h-pirido/3,2-a/fenoxazin-3-carboxilico. - Google Patents

Procedimiento para producir esteres de acido 1-hidroxi-5-oxo-5h-pirido/3,2-a/fenoxazin-3-carboxilico.

Info

Publication number
ES2031477T3
ES2031477T3 ES198787110051T ES87110051T ES2031477T3 ES 2031477 T3 ES2031477 T3 ES 2031477T3 ES 198787110051 T ES198787110051 T ES 198787110051T ES 87110051 T ES87110051 T ES 87110051T ES 2031477 T3 ES2031477 T3 ES 2031477T3
Authority
ES
Spain
Prior art keywords
pirido
phenoxazin
oxo
hydroxy
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787110051T
Other languages
English (en)
Inventor
Hideo Terayama
Jun Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2031477T3 publication Critical patent/ES2031477T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LOS COMPUESTOS REPRESENTADOS POR LA FORMULA GENERAL (I) EN LA QUE R ES UN GRUPO ALQUILO QUE TIENE DE 1 A 10 ATOMOS DE CARBONO SON NUEVOS COMPUESTOS SOBRE LOS QUE NO SE HA INFORMADO EN LA BIBLIOGRAFIA. COMO ESTOS TIENEN EXCELENTES AFINIDADES PARA LOS TEJIDOS CON UNA PERMEABILIDAD CORNEAL PARTICULARMENTE ALTA Y MUESTRAN ACTIVIDAD ANTICATARATA A BAJA CONCENTRACION, LOS COMPUESTOS SON VALIOSOS COMO AGENTES PROFILACTICOS Y TERAPEUTICOS PARA LA CATARATAS.
ES198787110051T 1986-07-15 1987-07-11 Procedimiento para producir esteres de acido 1-hidroxi-5-oxo-5h-pirido/3,2-a/fenoxazin-3-carboxilico. Expired - Lifetime ES2031477T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61166066A JPS6322584A (ja) 1986-07-15 1986-07-15 1−ハイドロキシ−5−オキソ−5H−ピリド〔3,2−a〕フエノキサジン−3−カルボン酸エステル類

Publications (1)

Publication Number Publication Date
ES2031477T3 true ES2031477T3 (es) 1992-12-16

Family

ID=15824343

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787110051T Expired - Lifetime ES2031477T3 (es) 1986-07-15 1987-07-11 Procedimiento para producir esteres de acido 1-hidroxi-5-oxo-5h-pirido/3,2-a/fenoxazin-3-carboxilico.

Country Status (12)

Country Link
US (1) US4820837A (es)
EP (1) EP0254167B1 (es)
JP (1) JPS6322584A (es)
KR (1) KR950008316B1 (es)
CN (1) CN1019299B (es)
AT (1) ATE58141T1 (es)
CA (1) CA1311477C (es)
DE (1) DE3766028D1 (es)
ES (1) ES2031477T3 (es)
GR (1) GR3001065T3 (es)
HU (1) HU196211B (es)
SU (1) SU1628858A3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU635045B2 (en) * 1989-07-20 1993-03-11 Asai Germanium Research Institute Co., Ltd Agent for preventing and treating opacity of lens
CN108558906A (zh) * 2018-05-21 2018-09-21 日照市普达医药科技有限公司 一种治疗白内障药物苯并吩噁嗪类化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59520B2 (ja) * 1974-07-19 1984-01-07 センジユセイヤク カブシキガイシヤ 1− ハイドロキシ −5− オキソ −5h− ピリド ( 3,2−a ) フエノキサジン −3− カルボンサン オヨビ ソノユウドウタイノセイセイホウ
JPS5270014A (en) * 1975-12-05 1977-06-10 Senju Pharma Co Stabilization of pyrido*3*22a*phenoxadine compounds
SE448091B (sv) * 1977-12-15 1987-01-19 Roussel Uclaf Nya 2-/(4-kinolinyl)-amino/-5-fluorbensoesyraderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa derivat
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives

Also Published As

Publication number Publication date
GR3001065T3 (en) 1992-03-20
CN1019299B (zh) 1992-12-02
KR880001666A (ko) 1988-04-26
JPH0236596B2 (es) 1990-08-17
SU1628858A3 (ru) 1991-02-15
EP0254167A1 (en) 1988-01-27
JPS6322584A (ja) 1988-01-30
US4820837A (en) 1989-04-11
HU196211B (en) 1988-10-28
ATE58141T1 (de) 1990-11-15
KR950008316B1 (ko) 1995-07-27
CN87104927A (zh) 1988-02-03
CA1311477C (en) 1992-12-15
HUT45062A (en) 1988-05-30
EP0254167B1 (en) 1990-11-07
DE3766028D1 (de) 1990-12-13

Similar Documents

Publication Publication Date Title
IE873355L (en) N-substituted carboxamides
ES486349A1 (es) Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas
DE3370478D1 (en) Isoquinolinesulfonamide derivatives and process for the preparation thereof
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
DE3370585D1 (en) Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation
MX9200063A (es) Derivados de acidos tetrahidrofolicos y procedimiento para su preparacion.
ES2063452T3 (es) Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos.
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
SE8604950L (sv) Demensforbettrande och terapeutiska medel
SE8902273D0 (sv) Indenoindole compounds i
ES2031477T3 (es) Procedimiento para producir esteres de acido 1-hidroxi-5-oxo-5h-pirido/3,2-a/fenoxazin-3-carboxilico.
AU3624089A (en) Analgesic phenothiazine derivatives
PL235882A1 (es)
DE3882623D1 (de) Phosphorsaeurediester und salze davon.
DE3167347D1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof
ES2059451T3 (es) Derivados de naftotiazepina y su procedimiento de preparacion.
FR2359836A1 (fr) Ethers de zearaline utiles comme agents promoteurs de la croissance
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
KR850007602A (ko) 트리아졸로피리미딘 유도체의 제조방법
GR3002699T3 (en) Process for stabilising procaterol
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 254167

Country of ref document: ES